NCAM1 and Miyoshi myopathy: discovered that a decrease in adhesion molecule expression in MM patients’ BM may contribute to the abundance of circulating PCs in the peripheral blood of patients with relapsed/refractory disease, resulting in the absence of CD49d, CD49e, CD56, CD138, and CD58 markers in circulating peripheral blood plasma samples (57).